Not that long ago, I wrote a blog on this topic entitled, “FDA Regulation of Homeopathy - What's Smoke? What's Fire? and How to Put it Out.” As a follow-up to that article, I wanted to provide you an update. FDA has extended their deadline for the public to submit comments and write letters to Members of Congress for an additional 60 days.
What does this mean?
In an effort to restore key language back into the draft guidance FDA uses to regulate homeopathic medicines, we are asking you to write a letter to your respective U.S. Members of Congress asking them to co-sign letters already written by Senator Orrin Hatch and Representative Ryan Costello. Sen. Hatch and Rep. Costello’s letters ask FDA to merge existing CPG (Compliance Policy Guide) 400.400 for the manufacturing of homeopathic medicines, which has been in place for over 30 years, with the new proposed FDA draft guidance proposed in December 2017.
Key language in CPG 400.400 can’t be understated. It incorporates solutions that provide uniformity in enforcement and clarity in regulation of homeopathic medicines, which is left out of the current state of draft guidance FDA is proposing. This will help ensure Americans have the safest and highest quality products for the personal health care choice that they want and deserve.
The reason the letters from Senator Hatch and Representative Costello are so important is that they sit on committees that oversee FDA. As such, their sponsorship of these letters is paramount to influencing FDA. And YOU can influence your legislator’s to co-sign these letters!
From the National Center for Homeopathy:
How to Contact your Legislators
The American Academy of Homeopathic Pharmacists (AAHP) recommends the following:
Whether you’re a consumer, supporter, or practitioner of homeopathy, thank you for your continued advocacy! It’s via the grassroots efforts from the likes of you that homeopathy will remain accessible and viable for all!
Thank you for reading.